v1
Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy.
Identifier:nobleid.org/w1/20260515/CF206306
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/CF206306)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →